| U.S. states allege broad generic drug price-fixing collusion | | | WASHINGTON (Reuters) - A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drugmakers and medicines in an action that sent some company shares tumbling. |
| |
| U.S. court bars Philips from selling some defibrillators | | | WASHINGTON (Reuters) - A federal court barred Philips North America LLC and two of its executives from distributing certain medical devices, including some of the company's external defibrillators, until the company takes remedial steps, the Department of Justice said on Tuesday. |
| |
| AstraZeneca wins early U.S. approval for blood cancer drug | | | LONDON (Reuters) - AstraZeneca has won U.S. approval for a new blood cancer drug several months earlier than expected, boosting its oncology portfolio - and requiring it to pay $1.5 billion to shareholders in the biotech company that first discovered the medicine. |
| |
| UK's NICE gives Roche drug green light for bladder cancer | | | LONDON (Reuters) - Britain's healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche's immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer. |
| |
| | |
